相关实验视频

Updated: Jan 15, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

联合联合会圆桌会议:脂质管理中的新疗法

Steven E Nissen¹, Ann Marie Navar², Daniel Gaudet³

¹Cleveland Clinic, Cleveland, OH (Dr Nissen).

Journal of clinical lipidology

|October 11, 2025

概括

新的脂质管理选择,包括bempedoic acid和obicetrapib,提供了预防动脉样硬化心血管疾病 (ASCVD) 的新方法. 这些药物向关键的脂质标记物,改善心血管健康的初级预防策略.

科学领域:

心脏病学心脏病学
药理学药理学是指药理学的学科.
脂质学脂质学是指脂质学.

背景情况:

动脉样性心血管疾病 (ASCVD) 仍然是导致死亡和残疾的主要原因.
有效地管理脂质概况对于ASCVD的预防和治疗至关重要.
目前的治疗选择有局限性,需要开发新药.

研究的目的:

讨论ASCVD新出现的脂质管理策略.
审查最近批准和正在研究的降脂剂.
突出新型疗法在ASCVD初级预防中的作用.

主要方法:

一个圆桌讨论形式,涉及脂质学领域的关键论领袖.
审查新的脂质管理选择,包括bempedoic酸和obicetrapib.
讨论目标脂质参数,如LDL-C,Lp(a),Apo B和甘油三等.

主要成果:

孟佩多酸 (ATP-酸酶抑制剂) 和奥比塞特拉皮 (CETP抑制剂) 被讨论为新的治疗选择.
抑制阿波利波蛋白C3 (Apo C3) 的药物也因其潜力而受到重视.
这些药物向多种异性质脂质颗粒和蛋白质,包括LDL-C,Lp(a),Apo B,甘油三,残留胆固醇和胆米克龙.
强调初级预防的重要性,在发生重大心血管不良事件之前应对风险因素.

结论:

新型降脂剂在治疗脱脂症方面取得了重大进展.
这些药物为临床医生提供了有前途的新工具,用于ASCVD的初级预防.
讨论者对将这些疗法纳入临床实践表示乐观.

关键词:

在C3的阿波利波蛋白中.贝佩多酸是贝佩多酸的一种酸.胆固醇转移蛋白抑制剂胆固醇转移蛋白抑制剂脂蛋白 (a) 是一种蛋白质低密度脂蛋白胆固醇是低密度脂蛋白胆固醇的一种.一个 Obicetrapib 的人.

更多相关视频

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

Lipidomics and Transcriptomics in Neurological Diseases

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

相关概念视频

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

Overview of Lipid Metabolism

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Hypertension IV: Drug Therapy and Lifestyle Modifications

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...